Novartis Gene Therapies Switzerland GmbH
Learn what cell and gene therapy is, how it differs from conventional medicine, and why it's creating a new turning point in how we treat disease.
Basic Information
- Category: business
- Founded: 2013
- Website: https://www.novartis.com/about/novartis-gene-therapies
Evidence and Sources
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Novartis Gene Therapies Switzerland GmbH.
- Canonical profile: https://brandsource.ai/brands/novartis-gene-therapies-switzerland-gmbh
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/novartis-gene-therapies-switzerland-gmbh/json-ld
- Citation profile API: https://brandsource.ai/api/brands/novartis-gene-therapies-switzerland-gmbh/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (82/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Learn what cell and gene therapy is, how it differs from conventional medicine, and why it's creating a new turning point in how we treat disease.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.